Results
|
201.
|
Phase II trial of combretastatin A4 phosphate, carboplatin, and paclitaxel in patients with platinum-resistant ovarian cancer. [electronic resource] by
- Zweifel, M
- Jayson, G C
- Reed, N S
- Osborne, R
- Hassan, B
- Ledermann, J
- Shreeves, G
- Poupard, L
- Lu, S-P
- Balkissoon, J
- Chaplin, D J
- Rustin, G J S
Producer: 20111128
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 22
Availability: No items available.
|
|
202.
|
Clinical trials in ovarian carcinoma: study methodology. [electronic resource] by
- Vermorken, J B
- Parmar, M K B
- Brady, M F
- Eisenhauer, E A
- Hogberg, T
- Ozols, R F
- Rochon, J
- Rustin, G J S
- Sagae, S
- Verheijen, R H M
Producer: 20060209
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 16 Suppl 8
Availability: No items available.
|
|
203.
|
A phase 1 study of tazarotene in adults with advanced cancer. [electronic resource] by
- Jones, P H
- Burnett, R D
- Fainaru, I
- Nadolny, P
- Walker, P
- Yu, Z
- Tang-Liu, D
- Ganesan, T S
- Talbot, D C
- Harris, A L
- Rustin, G J S
Producer: 20031023
In:
British journal of cancer vol. 89
Availability: No items available.
|
|
204.
|
A Phase Ib trial of CA4P (combretastatin A-4 phosphate), carboplatin, and paclitaxel in patients with advanced cancer. [electronic resource] by
- Rustin, G J
- Shreeves, G
- Nathan, P D
- Gaya, A
- Ganesan, T S
- Wang, D
- Boxall, J
- Poupard, L
- Chaplin, D J
- Stratford, M R L
- Balkissoon, J
- Zweifel, M
Producer: 20100528
In:
British journal of cancer vol. 102
Availability: No items available.
|
|
205.
|
Prognostic factors for patients with advanced seminoma treated with platinum-based chemotherapy. [electronic resource] by
- Fosså, S D
- Oliver, R T
- Stenning, S P
- Horwich, A
- Wilkinson, P
- Read, G
- Mead, G M
- Roberts, J T
- Rustin, G
- Cullen, M H
- Kaye, S B
- Harland, S J
- Cook, P
Producer: 19971103
In:
European journal of cancer (Oxford, England : 1990) vol. 33
Availability: No items available.
|
|
206.
|
A phase II trial evaluating two schedules of sagopilone (ZK-EPO), a novel epothilone, in patients with platinum-resistant ovarian cancer. [electronic resource] by
- Rustin, G
- Reed, N
- Jayson, G C
- Ledermann, J A
- Adams, M
- Perren, T
- Poole, C
- Lind, M
- Persic, M
- Essapen, S
- Gore, M
- Calvert, H
- Stredder, C
- Wagner, A
- Giurescu, M
- Kaye, S
Producer: 20111219
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 22
Availability: No items available.
|
|
207.
|
Radiotherapy versus single-dose carboplatin in adjuvant treatment of stage I seminoma: a randomised trial. [electronic resource] by
- Oliver, R T D
- Mason, M D
- Mead, G M
- von der Maase, H
- Rustin, G J S
- Joffe, J K
- de Wit, R
- Aass, N
- Graham, J D
- Coleman, R
- Kirk, S J
- Stenning, S P
Producer: 20051004
In:
Lancet (London, England) vol. 366
Availability: No items available.
|
|
208.
|
A multicenter, randomized trial of flat dosing versus intrapatient dose escalation of single-agent carboplatin as first-line chemotherapy for advanced ovarian cancer: an SGCTG (SCOTROC 4) and ANZGOG study on behalf of GCIG. [electronic resource] by
- Banerjee, S
- Rustin, G
- Paul, J
- Williams, C
- Pledge, S
- Gabra, H
- Skailes, G
- Lamont, A
- Hindley, A
- Goss, G
- Gilby, E
- Hogg, M
- Harper, P
- Kipps, E
- Lewsley, L-A
- Hall, M
- Vasey, P
- Kaye, S B
Producer: 20130730
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 24
Availability: No items available.
|
|
209.
|
Radiotherapy after chemotherapy for metastatic seminoma--a diminishing role. MRC Testicular Tumour Working Party. [electronic resource] by
- Duchesne, G M
- Stenning, S P
- Aass, N
- Mead, G M
- Fosså, S D
- Oliver, R T
- Horwich, A
- Read, G
- Roberts, I T
- Rustin, G
- Cullen, M H
- Kaye, S B
- Harland, S J
- Cook, P A
Producer: 19970924
In:
European journal of cancer (Oxford, England : 1990) vol. 33
Availability: No items available.
|
|
210.
|
O6-methylguanine-DNA methyltransferase in pretreatment tumour biopsies as a predictor of response to temozolomide in melanoma. [electronic resource] by
- Middleton, M R
- Lunn, J M
- Morris, C
- Rustin, G
- Wedge, S R
- Brampton, M H
- Lind, M J
- Lee, S M
- Newell, D R
- Bleehen, N M
- Newlands, E S
- Calvert, A H
- Margison, G P
- Thatcher, N
Producer: 19981201
In:
British journal of cancer vol. 78
Availability: No items available.
|
|
211.
|
An Adaptive Study to Determine the Optimal Dose of the Tablet Formulation of the PARP Inhibitor Olaparib. [electronic resource] by
- Mateo, J
- Moreno, V
- Gupta, A
- Kaye, S B
- Dean, E
- Middleton, M R
- Friedlander, M
- Gourley, C
- Plummer, R
- Rustin, G
- Sessa, C
- Leunen, K
- Ledermann, J
- Swaisland, H
- Fielding, A
- Bannister, W
- Nicum, S
- Molife, L R
Producer: 20171030
In:
Targeted oncology vol. 11
Availability: No items available.
|
|
212.
|
Conseusus statements on prognostic factors in epithelial ovarian carcinoma. Report of the Consensus Meeting organized by the European Society of Gynaecological Oncology, ESGO. [electronic resource] by
- Bösze, P
- Bast, R C
- Berchuck, A
- Burke, H B
- Buller, R E
- Creasman, W T
- Dubeau, L
- Fox, H
- Geisler, H E
- Geisler, J P
- Henson, D E
- Rustin, G J
- Vermorken, J B
- Wells, M
- Wilbanks, G D
Producer: 20010308
In:
European journal of gynaecological oncology vol. 21
Availability: No items available.
|
|
213.
|
High-dose etoposide with granulocyte colony-stimulating factor for mobilization of peripheral blood progenitor cells: efficacy and toxicity at three dose levels. [electronic resource] by
- Kanfer, E J
- McGuigan, D
- Samson, D
- Abboudi, Z
- Abrahamson, G
- Apperley, J F
- Chilcott, S
- Craddock, C
- Davis, J
- MacDonald, C
- Macdonald, D
- Olavarria, E
- Philpott, N
- Rustin, G J
- Seckl, M J
- Sekhar, M
- Stern, S
- Newlands, E S
Producer: 19981013
In:
British journal of cancer vol. 78
Availability: No items available.
|
|
214.
|
A randomised, phase II trial of the DNA-hypomethylating agent 5-aza-2'-deoxycytidine (decitabine) in combination with carboplatin vs carboplatin alone in patients with recurrent, partially platinum-sensitive ovarian cancer. [electronic resource] by
- Glasspool, R M
- Brown, R
- Gore, M E
- Rustin, G J S
- McNeish, I A
- Wilson, R H
- Pledge, S
- Paul, J
- Mackean, M
- Hall, G D
- Gabra, H
- Halford, S E R
- Walker, J
- Appleton, K
- Ullah, R
- Kaye, S
Producer: 20140605
In:
British journal of cancer vol. 110
Availability: No items available.
|
|
215.
|
Prognostic factors in patients progressing after cisplatin-based chemotherapy for malignant non-seminomatous germ cell tumours. [electronic resource] by
- Fosså, S D
- Stenning, S P
- Gerl, A
- Horwich, A
- Clark, P I
- Wilkinson, P M
- Jones, W G
- Williams, M V
- Oliver, R T
- Newlands, E S
- Mead, G M
- Cullen, M H
- Kaye, S B
- Rustin, G J
- Cook, P A
Producer: 19990805
In:
British journal of cancer vol. 80
Availability: No items available.
|
|
216.
|
A phase I study to determine the safety, pharmacokinetics and pharmacodynamics of a dual VEGFR and FGFR inhibitor, brivanib, in patients with advanced or metastatic solid tumors. [electronic resource] by
- Jonker, D J
- Rosen, L S
- Sawyer, M B
- de Braud, F
- Wilding, G
- Sweeney, C J
- Jayson, G C
- McArthur, G A
- Rustin, G
- Goss, G
- Kantor, J
- Velasquez, L
- Syed, S
- Mokliatchouk, O
- Feltquate, D M
- Kollia, G
- Nuyten, D S A
- Galbraith, S
Producer: 20111128
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 22
Availability: No items available.
|
|
217.
|
Assessment of antiangiogenic and antivascular therapeutics using MRI: recommendations for appropriate methodology for clinical trials. [electronic resource] by
- Leach, M O
- Brindle, K M
- Evelhoch, J L
- Griffiths, J R
- Horsman, M R
- Jackson, A
- Jayson, G
- Judson, I R
- Knopp, M V
- Maxwell, R J
- McIntyre, D
- Padhani, A R
- Price, P
- Rathbone, R
- Rustin, G
- Tofts, P S
- Tozer, G M
- Vennart, W
- Waterton, J C
- Williams, S R
- Workman, P
Producer: 20041214
In:
The British journal of radiology vol. 76 Spec No 1
Availability: No items available.
|
|
218.
|
The assessment of antiangiogenic and antivascular therapies in early-stage clinical trials using magnetic resonance imaging: issues and recommendations. [electronic resource] by
- Leach, M O
- Brindle, K M
- Evelhoch, J L
- Griffiths, J R
- Horsman, M R
- Jackson, A
- Jayson, G C
- Judson, I R
- Knopp, M V
- Maxwell, R J
- McIntyre, D
- Padhani, A R
- Price, P
- Rathbone, R
- Rustin, G J
- Tofts, P S
- Tozer, G M
- Vennart, W
- Waterton, J C
- Williams, S R
- Workman, P
Producer: 20050609
In:
British journal of cancer vol. 92
Availability: No items available.
|
|
219.
|
Chemotherapy for ovarian cancer--a consensus statement on standard practice. [electronic resource] by
- Adams, M
- Calvert, A H
- Carmichael, J
- Clark, P I
- Coleman, R E
- Earl, H M
- Gallagher, C J
- Ganesan, T S
- Gore, M E
- Graham, J D
- Harper, P G
- Jayson, G C
- Kaye, S B
- Ledermann, J A
- Osborne, R J
- Perren, T J
- Poole, C J
- Radford, J A
- Rustin, G J
- Slevin, M L
- Smyth, J F
- Thomas, H
- Wilkinson, P M
Producer: 19981207
In:
British journal of cancer vol. 78
Availability: No items available.
|
|
220.
|
Advanced epithelial ovarian cancer: 1998 consensus statements. [electronic resource] by
- Berek, J S
- Bertelsen, K
- du Bois, A
- Brady, M F
- Carmichael, J
- Eisenhauer, E A
- Gore, M
- Grenman, S
- Hamilton, T C
- Hansen, S W
- Harper, P G
- Horvath, G
- Kaye, S B
- Lück, H J
- Lund, B
- McGuire, W P
- Neijt, J P
- Ozols, R F
- Parmar, M K
- Piccart-Gebhart, M J
- van Rijswijk, R
- Rosenberg, P
- Rustin, G J
- Sessa, C
- Willemse, P H
Producer: 19990611
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 10 Suppl 1
Availability: No items available.
|